samedan logo
 
 
spacer
home > pmps > summer 2019 > redefining supply
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Redefining Supply

Passive packaging is coming of age. In a world where door-to-door delivery is transforming the consumer experience, more and more sectors are waking up to the possibilities of delivering temperature-controlled products in a simple, cost-effective, and reliable way.

As the world faces the challenges of global warming, new approaches to packaging also provide opportunities to reassess the impact of supply chains on the planet. However, while industries such as retail and food have been quick to adopt new forms of delivery, they do so without the strict regulations and restraints that often apply to the pharmaceutical sector.

As Managing Director of a company that has invested millions in R&D for passive packaging solutions, I am well aware of both the challenges and benefits they can bring to pharma customers, and, as a passionate believer in the properties of natural materials, I appreciate the particular challenges a more ecological packaging approach presents to this most scientific of sectors.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Josie Morris BA (Hons), MA, is Managing Director at The Wool Packaging Company Ltd (Woolcool). A passionate advocate for diversity and the development of strong cultures within innovative businesses, Josie is also closely involved with organisations such as the Bio-Based Industries Association (BBIA), which lobby the UK government on the environmental problems of global packaging waste and support pioneering companies such as Woolcool that offer genuinely sustainable alternatives to plastic materials.
spacer
josie@woolcool.com
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera reinforces its value proposition with a refreshing visual identity

At Nemera, we have been successfully providing high quality drug delivery device solutions to our customers and patients for years. We design and manufacture devices with the ultimate goal to improve patient outcomes and experience.
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence and Post Translational Modifications of a Monoclonal Antibody

RSSL

Monoclonal antibodies are an important class of biopharmaceuticals. They are expressed from living cells and therefore, are subject to complex biochemical pathways. Not all of these pathways are fully understood and many are known to be sensitive to subtle environmental changes during production. These changes may affect the final biopharmaceutical sequence, structure and post-translational modifications. This is in addition to any changes that may occur during subsequent purification. This means that the final product from one batch may be subtly different from another batch. Furthermore, each batch is a heterogeneous mix of similar molecules. Analysis of the degree of batch-tobatch variation, and batch heterogeneity, is therefore, very important to establish in order to be confident that the drug is safe and effective for medicinal use.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement